Eventide Asset Management, LLC Aura Biosciences, Inc. Transaction History
Eventide Asset Management, LLC
- $5.68 Billion
- Q2 2024
A detailed history of Eventide Asset Management, LLC transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Eventide Asset Management, LLC holds 5,802,682 shares of AURA stock, worth $63.8 Million. This represents 0.77% of its overall portfolio holdings.
Number of Shares
5,802,682
Previous 5,802,682
-0.0%
Holding current value
$63.8 Million
Previous $45.6 Million
3.69%
% of portfolio
0.77%
Previous 0.73%
Shares
5 transactions
Others Institutions Holding AURA
# of Institutions
79Shares Held
40.3MCall Options Held
800Put Options Held
1.8K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$76.2 Million0.4% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.89MShares$53.7 Million0.07% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$33.4 Million5.63% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$33.1 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.34MShares$25.7 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $322M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...